Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous intraoperative ketamine infusion for postoperative pain after thoracoscopic lobectomy
ChiCTR2100046970Phase 4Recruiting
- Sponsor
- Cancer Prevention Center
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ketamine in bronchial carcinoma (3 arms), sponsored by Cancer Prevention Center. Primary endpoints: Mechanical pain threshold and Digital Pain Rating Scale (NRS score). Started Jul 2021; status: recruiting.
02
Drugs
ketamine
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR2100046970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046970.